Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
276
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $39.5M | 0.09% |
821,500
+314,200
| +62% | +$16M |
|
|
MLNX
277
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $39.4M | 0.09% |
935,583
+118,399
| +14% | +$5.26M |
|
|
WNS
278
DELISTED
WNS Holdings
WNS
| $39.2M | 0.09% |
1,255,803
+17,803
| +1% | +$557K |
|
279
Royal Caribbean
RCL
$82.1B
| $39M | 0.09% |
385,414
+381,799
| +10,562% | +$36.4M |
|
280
Ameriprise Financial
AMP
$49.7B
| $38.9M | 0.08% |
365,100
-119,100
| -25% | -$13.3M |
|
281
Skyworks Solutions
SWKS
$10.3B
| $38.7M | 0.08% |
+503,183
| New | +$40.3M |
|
282
Travel + Leisure Co
TNL
$4.52B
| $38.6M | 0.08% |
1,176,608
+737,659
| +168% | +$25.4M |
|
|
OA
283
DELISTED
Orbital ATK, Inc.
OA
| $38.4M | 0.08% |
430,102
-1,555
| -0.4% | -$131K |
|
284
SLM Corp
SLM
$5.11B
| $38.4M | 0.08% |
5,887,100
+3,779,900
| +179% | +$25.7M |
|
285
Groupon
GRPN
$889M
| $38.1M | 0.08% |
620,260
+82,005
| +15% | +$5.27M |
|
286
Emergent Biosolutions
EBS
$228M
| $38.1M | 0.08% |
951,611
+177,400
| +23% | +$6.19M |
|
287
Fidelity National Financial
FNF
$12.8B
| $38.1M | 0.08% |
1,581,005
+529,635
| +50% | +$12.9M |
|
288
Kearny Financial
KRNY
$600M
| $37.9M | 0.08% |
2,994,001
-439,420
| -13% | -$5.35M |
|
289
Eversource Energy
ES
$26.8B
| $37.9M | 0.08% |
742,000
-119,380
| -14% | -$6.07M |
|
|
RPAI
290
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $37.5M | 0.08% |
2,541,055
-111,902
| -4% | -$1.66M |
|
|
WR
291
DELISTED
Westar Energy Inc
WR
| $37.5M | 0.08% |
883,700
+51,300
| +6% | +$2.1M |
|
292
Wabtec
WAB
$50.3B
| $37.4M | 0.08% |
525,300
+436,200
| +490% | +$34.8M |
|
293
Equifax
EFX
$21.4B
| $37.2M | 0.08% |
334,395
-60,125
| -15% | -$6.5M |
|
|
BNCL
294
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $37.1M | 0.08% |
2,786,870
-51,700
| -2% | -$708K |
|
295
US Physical Therapy
USPH
$1.22B
| $37.1M | 0.08% |
691,200
-59,017
| -8% | -$2.96M |
|
296
Akamai
AKAM
$16.8B
| $37M | 0.08% |
+703,300
| New | +$43.2M |
|
|
PDLI
297
DELISTED
PDL BioPharma, Inc.
PDLI
| $36.6M | 0.08% |
10,345,559
+1,349,405
| +15% | +$5.65M |
|
298
Republic Services
RSG
$65.9B
| $36.5M | 0.08% |
830,861
-138,800
| -14% | -$6.06M |
|
299
Johnson Controls International
JCI
$93.7B
| $36.1M | 0.08% |
+872,679
| New | +$39.5M |
|
|
VVC
300
DELISTED
Vectren Corporation
VVC
| $35.7M | 0.08% |
842,700
-101,700
| -11% | -$4.37M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.